A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials

Clinical trial NCT02510300 · TERMINATED

Trial details

NCT number: NCT02510300
Sponsor: Gilead Sciences
Status: TERMINATED
Study type: OBSERVATIONAL

Hepatitis C Virus Infection

Start date: 2015-10-21
Primary completion: 2023-01-06
Enrollment: 461

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.